Latest Advertising News

News Corporation reported a modest 1% revenue increase to $2.01 billion and a striking 67% jump in net income for Q3 Fiscal 2025, driven by digital subscription growth and strategic asset realignment including the Foxtel sale.

Gumtree Australia Markets and NZME have signed an MOU to explore launching a new digital automotive marketplace in New Zealand, aiming to challenge the current market leader and tap into a $125 million annual revenue opportunity.

ARN Media Limited’s 2025 AGM update highlights robust financial health, a strategic $40 million transformation program, and strong digital audio momentum despite a modest revenue dip year-to-date.

ARN Media reports resilient 2024 financials driven by digital growth and Cody Outdoor contracts, launching a major cost-cutting transformation to sharpen its competitive edge.

Nine Entertainment reports solid Q3 advertising revenue growth and cost efficiencies while advancing a major stake sale in Domain, positioning the media giant for strategic expansion.

Southern Cross Media Group reports robust audio revenue growth exceeding expectations and signals a return to dividends for FY25, underpinned by disciplined cost management.

Seven West Media has agreed to acquire Southern Cross Media's television licences, completing its national broadcast network and boosting its digital and live TV offerings across Australia.

Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.

CL8 Holdings Limited reported strong subscriber growth and revenue gains in the March 2025 quarter, while preparing to sell its operating entities to streamline costs and improve cash flow.

Codeifai Limited reports a robust 141% increase in Q1 2025 cash receipts, driven by its revamped Digital First Engagement First strategy and the expanding ConnectQR SaaS platform. Despite rising costs, the company maintains strong margins and is strategically reviewing its Material Science division.

Tissue Repair Limited reports progress in its Phase 3 clinical trials for TR987® despite enrollment delays caused by US regulatory disruptions, while TR Pro+® sales hit record highs and manufacturing scale-up advances.

Starpharma reports steady progress in its DEP® drug development programs, launches new marketing campaigns in key regions, and maintains a strong cash position of $17.2 million as it refines clinical strategies and partnerships.